{"entity":{"type":"insider","cik":"0002004380","url":"/insider/0002004380","json_url":"/insider/0002004380.json","name":"Lippis Daniel J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":22,"first":"2024-03-07","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Lippis Daniel J.","source":"filing","n_filings":22,"first_seen":"2024-03-07","last_seen":"2026-08-11"}],"transactions":[{"id":9275333,"accession":"0001225208-26-007065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-26-007065","line_url":"/filing/0001225208-26-007065#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":619.0,"shares_display":"619","price_per_share":92.03,"price_display":"92.03","price_state":"stated","total_value":56966.57,"total_display":"56,966.57","total_whole":"56,967","shares_owned_after":40033.9103,"shares_owned_after_display":"40,033.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-11","scope":"insider"},{"id":5826741,"accession":"0001225208-26-006576","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-006576","line_url":"/filing/0001225208-26-006576#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":619.0,"shares_display":"619","price_per_share":91.7,"price_display":"91.70","price_state":"stated","total_value":56762.3,"total_display":"56,762.30","total_whole":"56,762","shares_owned_after":40033.9103,"shares_owned_after_display":"40,033.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-10","scope":"insider"},{"id":5931351,"accession":"0001225208-26-006263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-006263","line_url":"/filing/0001225208-26-006263#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":619.0,"shares_display":"619","price_per_share":91.4002,"price_display":"91.40","price_state":"stated","total_value":56576.7238,"total_display":"56,576.72","total_whole":"56,577","shares_owned_after":40410.9103,"shares_owned_after_display":"40,410.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-06-30","scope":"insider"},{"id":6155712,"accession":"0001225208-26-005464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-005464","line_url":"/filing/0001225208-26-005464#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":620.0,"shares_display":"620","price_per_share":81.14,"price_display":"81.14","price_state":"stated","total_value":50306.8,"total_display":"50,306.80","total_whole":"50,307","shares_owned_after":40410.9103,"shares_owned_after_display":"40,410.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-18","scope":"insider"},{"id":6203949,"accession":"0001225208-26-004909","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001225208-26-004909","line_url":"/filing/0001225208-26-004909#line-6","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":83.98,"price_display":"83.98","price_state":"stated","total_value":85575.62,"total_display":"85,575.62","total_whole":"85,576","shares_owned_after":33681.9103,"shares_owned_after_display":"33,681.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-04","scope":"insider"},{"id":6203939,"accession":"0001225208-26-004909","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-26-004909","line_url":"/filing/0001225208-26-004909","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":83.00752894995094,"price_display":"83.01","price_state":"stated","total_value":84584.672,"total_display":"84,584.67","total_whole":"84,585","shares_owned_after":33933.9103,"shares_owned_after_display":"33,933.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider","n_lines":2},{"id":5774751,"accession":"0001225208-26-004422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-004422","line_url":"/filing/0001225208-26-004422#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":80.984,"price_display":"80.98","price_state":"stated","total_value":82522.696,"total_display":"82,522.70","total_whole":"82,523","shares_owned_after":33933.9103,"shares_owned_after_display":"33,933.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-06","scope":"insider"},{"id":6118374,"accession":"0001225208-26-003538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-003538","line_url":"/filing/0001225208-26-003538#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":85.3822,"price_display":"85.38","price_state":"stated","total_value":87004.4618,"total_display":"87,004.46","total_whole":"87,004","shares_owned_after":33933.9103,"shares_owned_after_display":"33,933.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-11","scope":"insider"},{"id":6090192,"accession":"0001225208-26-000558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-26-000558","line_url":"/filing/0001225208-26-000558#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, TAVR)","role_mark":"O","role_mark_label":"Officer (CVP, TAVR)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, TAVR","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":85.7037,"price_display":"85.70","price_state":"stated","total_value":87332.0703,"total_display":"87,332.07","total_whole":"87,332","shares_owned_after":22001.9103,"shares_owned_after_display":"22,001.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-09","scope":"insider"},{"id":5072166,"accession":"0001225208-25-009934","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-009934","line_url":"/filing/0001225208-25-009934#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1019.0,"shares_display":"1,019","price_per_share":84.0287,"price_display":"84.03","price_state":"stated","total_value":85625.2453,"total_display":"85,625.25","total_whole":"85,625","shares_owned_after":22001.9103,"shares_owned_after_display":"22,001.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-12","scope":"insider"},{"id":4493357,"accession":"0001225208-25-009066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-009066","line_url":"/filing/0001225208-25-009066#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1020.0,"shares_display":"1,020","price_per_share":82.5451,"price_display":"82.55","price_state":"stated","total_value":84196.002,"total_display":"84,196.00","total_whole":"84,196","shares_owned_after":22001.9103,"shares_owned_after_display":"22,001.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-10","scope":"insider"},{"id":4273854,"accession":"0001225208-25-006815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-25-006815","line_url":"/filing/0001225208-25-006815#line-1","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4114.0,"shares_display":"4,114","price_per_share":79.4605,"price_display":"79.46","price_state":"stated","total_value":326900.497,"total_display":"326,900.50","total_whole":"326,900","shares_owned_after":22001.9103,"shares_owned_after_display":"22,001.91","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-28","scope":"insider"},{"id":4032312,"accession":"0001225208-25-004947","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001225208-25-004947","line_url":"/filing/0001225208-25-004947#line-3","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":330.0,"shares_display":"330","price_per_share":74.4232,"price_display":"74.42","price_state":"stated","total_value":24559.656,"total_display":"24,559.66","total_whole":"24,560","shares_owned_after":26616.1066,"shares_owned_after_display":"26,616.11","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-09","scope":"insider"},{"id":4049358,"accession":"0001225208-25-004176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-004176","line_url":"/filing/0001225208-25-004176#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":70.61,"price_display":"70.61","price_state":"stated","total_value":21183.0,"total_display":"21,183.00","total_whole":"21,183","shares_owned_after":22863.1066,"shares_owned_after_display":"22,863.11","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-08","filed_date":"2025-04-08","scope":"insider"},{"id":5144751,"accession":"0001225208-25-003194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-003194","line_url":"/filing/0001225208-25-003194#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":69.48,"price_display":"69.48","price_state":"stated","total_value":27792.0,"total_display":"27,792.00","total_whole":"27,792","shares_owned_after":22588.0651,"shares_owned_after_display":"22,588.07","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-10","scope":"insider"},{"id":4533806,"accession":"0001225208-25-001710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-001710","line_url":"/filing/0001225208-25-001710#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":76.34,"price_display":"76.34","price_state":"stated","total_value":38170.0,"total_display":"38,170.00","total_whole":"38,170","shares_owned_after":23189.0651,"shares_owned_after_display":"23,189.07","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-13","scope":"insider"},{"id":4345582,"accession":"0001225208-25-000685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-25-000685","line_url":"/filing/0001225208-25-000685#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":68.7643,"price_display":"68.76","price_state":"stated","total_value":34382.15,"total_display":"34,382.15","total_whole":"34,382","shares_owned_after":23189.0651,"shares_owned_after_display":"23,189.07","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-16","scope":"insider"},{"id":2854755,"accession":"0001225208-24-010858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-010858","line_url":"/filing/0001225208-24-010858#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":74.0783,"price_display":"74.08","price_state":"stated","total_value":185195.75,"total_display":"185,195.75","total_whole":"185,196","shares_owned_after":23189.0651,"shares_owned_after_display":"23,189.07","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-16","scope":"insider"},{"id":2214994,"accession":"0001225208-24-007400","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-007400","line_url":"/filing/0001225208-24-007400#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":94.18,"price_display":"94.18","price_state":"stated","total_value":47090.0,"total_display":"47,090.00","total_whole":"47,090","shares_owned_after":23189.0651,"shares_owned_after_display":"23,189.07","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-11","scope":"insider"},{"id":2796488,"accession":"0001225208-24-006926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-006926","line_url":"/filing/0001225208-24-006926#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535.0,"shares_display":"535","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":48150.0,"total_display":"48,150.00","total_whole":"48,150","shares_owned_after":23512.7443,"shares_owned_after_display":"23,512.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-20","scope":"insider"},{"id":2322400,"accession":"0001225208-24-005890","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001225208-24-005890","line_url":"/filing/0001225208-24-005890#line-5","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":857.0,"shares_display":"857","price_per_share":85.6,"price_display":"85.60","price_state":"stated","total_value":73359.2,"total_display":"73,359.20","total_whole":"73,359","shares_owned_after":23889.7443,"shares_owned_after_display":"23,889.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-07","filed_date":"2024-05-09","scope":"insider"},{"id":2061295,"accession":"0001225208-24-005020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-005020","line_url":"/filing/0001225208-24-005020#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":857.0,"shares_display":"857","price_per_share":92.34,"price_display":"92.34","price_state":"stated","total_value":79135.38,"total_display":"79,135.38","total_whole":"79,135","shares_owned_after":17487.7443,"shares_owned_after_display":"17,487.74","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-09","scope":"insider"},{"id":3248925,"accession":"0001225208-24-003866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-24-003866","line_url":"/filing/0001225208-24-003866#line-2","is_derivative":false,"issuer_cik":"0001099800","issuer_name":"Edwards Lifesciences Corp","issuer_ticker":"EW","issuer_name_source":null,"issuer_url":"/issuer/0001099800","owner_cik":"0002004380","owner_name":"Lippis Daniel J.","owner_display_name":"Lippis Daniel J.","owner_url":"/insider/0002004380","role":"Officer (CVP, JAPAC)","role_mark":"O","role_mark_label":"Officer (CVP, JAPAC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP, JAPAC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1715.0,"shares_display":"1,715","price_per_share":90.98,"price_display":"90.98","price_state":"stated","total_value":156030.7,"total_display":"156,030.70","total_whole":"156,031","shares_owned_after":17213.2105,"shares_owned_after_display":"17,213.21","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001099800","name":"Edwards Lifesciences Corp","url":"/issuer/0001099800","role":"Officer (CVP, TAVR)","n_filings":22,"first_seen":"2024-03-07","last_seen":"2026-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002004380","retrieved_at":"2026-08-22T11:03:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}